scholarly journals Postpartum haemorrhage trends in Sweden using the Robson 10‐group classification system: A population‐based cohort study

Author(s):  
Linnea V. Ladfors ◽  
Giulia M. Muraca ◽  
Johan Zetterqvist ◽  
Alexander Butwick ◽  
Olof Stephansson
2020 ◽  
Vol 7 (5) ◽  
pp. 3095-3108
Author(s):  
Inge Schjødt ◽  
Søren P. Johnsen ◽  
Anna Strömberg ◽  
Jan B. Valentin ◽  
Brian B. Løgstrup

2018 ◽  
Vol 219 (1) ◽  
pp. 105.e1-105.e11 ◽  
Author(s):  
Mark P. Hehir ◽  
Cande V. Ananth ◽  
Zainab Siddiq ◽  
Karen Flood ◽  
Alexander M. Friedman ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Rong Lin ◽  
Peng Shi ◽  
Haibing Li ◽  
Zhiqiang Liu ◽  
Zhendong Xu

Abstract Background In this study, we aimed to determine whether epidural analgesia affects the indications for intrapartum caesarean delivery, such as foetal distress, dystocia, or maternal request, in nulliparous term women with spontaneous labour (Group 1 in the 10-Group Classification System). Methods We conducted a retrospective cohort study and collected data from the electronic medical records of deliveries performed in our institution between 1 January 2017 and 30 June 2017. Women conforming to the criterion of Group 1 according to the 10-Group Classification System were enrolled. We compared labour outcomes between women with and without epidural analgesia and analysed the association between epidural analgesia and indications for caesarean by using multivariate logistic regression analysis. Results A total of 3212 women met the inclusion criteria, and 2876 were enrolled in the final analyses. Women who received epidural analgesia had a significantly lower intrapartum caesarean delivery rate (16.0% vs. 26.7%, P < 0.001), higher rates of amniotomy (53.4% vs. 42.3%, P < 0.001) and oxytocin augmentation (79.5% vs. 67.0%, P < 0.001), and a higher incidence of intrapartum fever (≥38 °C) (23.3% vs. 8.5%, P < 0.001) than those who did not receive epidural analgesia. There were no significant differences between the groups for most indications, except a lower probability of maternal request for caesarean delivery (3.9% vs. 10.5%, P < 0.001) observed in women who received epidural analgesia than in those who did not. Epidural analgesia was revealed to be associated with a decreased risk of maternal request for caesarean delivery (adjusted odds ratio [aOR], 0.30; 95% confidence interval [CI], 0.22–0.42; P < 0.001); however, oxytocin augmentation was related to an increased risk of maternal request (aOR, 2.34; 95%CI, 1.47–3.75; P < 0.001). Regarding the reasons for the maternal request for caesarean delivery, significantly fewer women complained of pain (0.5% vs. 4.6%, P < 0.001) or had no labour progress (1.3% vs. 3.6%, P < 0.001) among those who received analgesia. Conclusions Among the women in Group 1, epidural analgesia was associated with a lower intrapartum caesarean delivery rate, which may be explained by a reduction in the risk of maternal request for an intrapartum caesarean delivery.


PLoS ONE ◽  
2019 ◽  
Vol 14 (8) ◽  
pp. e0220693 ◽  
Author(s):  
Tahmina Begum ◽  
Herfina Nababan ◽  
Aminur Rahman ◽  
Md Rajibul Islam ◽  
Alayne Adams ◽  
...  

Author(s):  
Е.А. Сотникова ◽  
М.В. Климушина ◽  
А.В. Киселева ◽  
О.П. Скирко ◽  
О.В. Курилова ◽  
...  

Целью работы было создание панели для скрининга носительства мутаций, связанных с развитием муковисцидоза (МВ), и апробация панели в популяционной выборке ЭССЕ-Вологда. В исследование вошли 642 участника из популяционной выборки региона Вологды. Детекцию мутаций осуществляли с помощью системы QuantStudio 12K Flex Real-Time PCR. Создана скрининговая панель, включающая 60 мутаций гена CFTR. Среди 642 участников исследования выявлено 23 гетерозиготных носителя 6 мутаций, связанных с развитием МВ, частота носительства составила 3,58% (ДИ 95%: 2,28-5,33%) или 1:28 чеовек. Разработанная панель может быть использована для скрининга гетерозиготных носителей МВ. The aim of the study was to create a panel for screening the carriers of mutations associated with the development of cystic fibrosis (CF), and testing the panel on 642 participants of the population-based cohort study (ESSE-Vologda). Variants were detected using the QuantStudio 12K Flex Real-Time PCR system. A custom panel that includes 60 CFTR variants was created. Among 642 participants in the study, 23 heterozygous carriers of 6 CFTR mutations were identified. The carrier frequency was 3.58% (CI95%: 2.28-5.33%) or 1:28. The custom panel can be used for screening heterozygous CF carriers.


Sign in / Sign up

Export Citation Format

Share Document